Kanso Diagnostics
Molecular Testing Platform
Active
Seed
Startup
Or Yehuda
Founded 2022-03
Kanso diagnostics develop a molecular testing platform for diagnosis of bacterial and viral infections. The company's solution aims to change the contemporary diagnostics experience, and the platform facilitates the at-home medical revolution, ensuring accessibility and ease of use. Kanso's novel technology accurately detects multiple pathogens and genetic…
SectorHealth Tech & Life Sciences
StageSeed
Total raised$1.5M
Employees7
Founded2022-03
HQOr Yehuda
Patents1
Confidence80
Sectors
Health Tech & Life SciencesMedical DevicesAssistive DevicesDiagnostics Devices
Technology
BiologicalsMicroorganismsGenesMolecules
Target customers
Healthcare & Life SciencesHealthcarePatientsInsurance CompaniesProvidersMedical Devices Industry